Nov 13 (Reuters) - Eye-care group Alcon (ALCC.S), opens new tab cut its 2024 forecasts and missed market expectations for third-quarter sales on Tuesday evening, as a soft U.S. market hit its surgical ...
Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...
With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...
It takes years of intense study and a steady hand for humans to perform surgery, but robots might have an easier time picking ...
SCSU’s MedTech programs give students more than a degree — they open doors to an exciting field that has the power to change ...
The AI learned by watching hundreds of videos of robot operations driven by human docs The AI now is as skillful as human ...
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
Zacks.com on MSN5d
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...
VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback